• 13 May 2003

SA government gets chance to rethink AIDS treatment policy

Read the article
  • 14 May 2003

HIV-positive gay men not a risk group for HCV coinfection in US urban cohort

Read the article
  • 14 May 2003

Atazanavir in treatment-experienced people: boosted looks better

Read the article
  • 14 May 2003

Atazanavir approval recommended in US

Read the article
  • 15 May 2003

Chronic HCV transmitted by tattooing, but unlikely to cause acute symptoms

Read the article
  • 15 May 2003

31% of African TB now due to HIV epidemic

Read the article
  • 16 May 2003

HIV protein mutation may explain long-term nonprogression

Read the article
  • 16 May 2003

No clear answer on what increases cancer risk in HIV-positive children in US study

Read the article
  • 19 May 2003

High levels of HDL cholesterol associated with longer undetectable viral load in HAART patients

Read the article
  • 19 May 2003

The longer HIV-positive drug users have HIV, then greater the risk of active TB

Read the article
  • 20 May 2003

Atazanavir resistance: independent study finds high cross-resistance to atazanavir

Read the article
  • 20 May 2003

HIV treatment interruption reported successful in African children

Read the article
  • 20 May 2003

Drug level monitoring succesful at reducing treatment failure in nelfinavir-treated HIV patients

Read the article
  • 21 May 2003

GlaxoSmithKline licenses new HIV and HBV drug from Swedish company

Read the article
  • 22 May 2003

HIV drug resistance can persist three years after transmission

Read the article
  • 22 May 2003

Abacavir linked to psychosis in HIV-positive woman

Read the article
  • 23 May 2003

'Heavy drinking' means HAART works less well in HIV-positive drug users

Read the article
  • 23 May 2003

Treating latent TB

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.